Pittenger & Anderson Inc Tg Therapeutics, Inc. Transaction History
Pittenger & Anderson Inc
- $2.64 Billion
- Q3 2025
A detailed history of Pittenger & Anderson Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Pittenger & Anderson Inc holds 612 shares of TGTX stock, worth $20,618. This represents 0.0% of its overall portfolio holdings.
Number of Shares
612Holding current value
$20,618% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
407Shares Held
91.5MCall Options Held
2.28MPut Options Held
1.68M-
Vanguard Group Inc Valley Forge, PA15.8MShares$533 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$384 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$257 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$118 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$103 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.89B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...